I. Assay characteristics
The method is based on a commercially available multiplex STR (short tandem repeat) PCR kit originally designed for forensic purposes (genetic fingerprinting). Nine different STR markers and the amelogenin locus are co-amplified in a single reaction. Separation of the PCR products and fluorescence detection are performed either on gel-based sequencers or capillary electrophoresis instruments. Calculation of donor chimerism is based on the ratio of informative donor and recipient signals.
II. Protocol
It is assumed that the user is familiar with the sequencing instrument. Reading of the AmpFlSTR Profiler PCR Amplification Kit user manual is strongly recommended prior to starting the assay.
DNA preparation
The quality of input DNA is important. Satisfactory results are obtained, eg with standard phenol/chloroform extraction or the Qiagen DNA Blood Kit (Qiagen, Hilden Germany), while salting-out procedures yield inconsistent results. Accurate DNA quantification (spectrophotometry) is an essential step because optimal results are only obtained within a narrow range of template DNA: 0.5-5 ng per PCR reaction. The DNA solution should be incubated for 30 min at 60°C prior to quantification to ensure that the solution is homogeneous. This step is particularly important when working with dried DNA pellets obtained, eg by phenol/chloroform extraction procedures. After quantification, DNA is diluted to a final concentration of 0.125 ng/l in 10 l TE buffer. When small cell subsets isolated by flow-sorting are analyzed, DNA extracted from about 500 cells is used as template in individual PCR reactions.
PCR
The PCR reaction is set up as described in the Profiler-STR user manual (PE Biosystems) in a final volume of 25 l: master-mix preparation (all reagents are included in the kit): 10.5 l PCR buffer, 0.5 l AmpliTaq Gold DNA polymerase and 5.5 l of primer mix per sample (=16 l/sample to compensate for potential losses during the subsequent pipetting steps). Fifteen microliters of the master-mix are added to 10 l template DNA.
The PCR protocol has been optimized for the PE 9600 thermocycler. For other cyclers, the parameters may need to be adjusted, especially the ramping time (1°C/s). After an initial incubation step at 95°C for 11 min to activate the hot-start Taq polymerase, 28 cycles are performed using the following profile: denaturation at 94°C for 1 min, annealing at 59°C for 1 min and extension at 72°C for 1 min, with a final elongation step at 60°C for 45 min. The final step is needed to obtain quantitative generation of 'A' overhangs, which are important to avoid formation of double peaks. After PCR, the samples are stored at 4°C in the dark.
Gel electrophoresis (a) Sequencing gel:
A denaturing 5% Long Ranger gel is used. Composition: 18 g urea, 5 ml Long Ranger gel solution, 5 ml 10× TBE buffer and 26.5 ml deionized water. For polymerization 250 l APS and 35 l TEMED are added. Combs: shark tooth or square tooth (48 slots). After polymerization (usually in 2 h), the gel plates are mounted. A prerun of at least 20 min should be performed in order to achieve homogeneous warming of the gel.
Four microliters of the PCR reaction are mixed with 5 l of a solution containing 4.5 l formamide and 0.5 l of the size standard Genescan ROX 500. The samples are denatured at 95°C for 2 min, and immediately chilled on ice for at least 2 min. After rinsing of slots with 1 × TBE buffer, 1.5 l are loaded on to the gel.
(b) Capillary electrophoresis (eg ABI Prism 310 Genetic Analyzer):
For fragment analysis, the POP-4 polymer, the 'green' 47 cm capillary and the 10 × 310 GA Buffer with EDTA are used. A 1.5 l portion of the PCR reaction is mixed with 25 l of a solution containing 24.5 l deionized formamide and 0.5 l Genescan ROX 500 size standard. The samples are denatured at 95°C for 3 min and chilled for at least 3 minutes in an ice-water bath. After placing the specimens in the sample rack, different injection times, eg 5 s, 10 s, and/or 15 s, 20 s are programmed. The loading of increasing amounts of PCR product permits the identification of optimum peak sizes for quantitative analysis.
Quantification of donor chimerism
After electrophoresis, the analysis of chimerism is performed by using the Genescan 3.x software. For each sample, the corresponding fluorescence curves are printed. For convenience, the pre-transplant donor and recipient samples should be printed on one page aligned in the 'size' modus to obtain rapid information on informative, ie different peak constellations. The peaks belonging to the recipient and the donor are marked in the table printed below the electropherogram to get information on their size. Informative peaks, ie those which are different between recipient and donor, are then Leukemia identified in post-transplant samples, according to their size. The calculation can be performed either manually or using an Excel spreadsheet (can be obtained upon request from C Thiede, address see below) using the algorithms in Figure 1A . 1 The peak area or the peak height can be used for the calculations, 24 although the former may be preferable. Besides noninformative STR markers displaying identical peaks in donor and recipient samples, three different constellations may be present (shown schematically in Figure 9 ), each requiring a slightly different approach to obtain quantitative information: Although calculation of donor chimerism is possible even in this situation as indicated below, the variance obtained is considerably higher. It is preferable therefore to exclude markers displaying this constellation from quantitative analysis of chimerism. % donor = 100 × area B (area A − area B)/2 + area B Donor chimerism is established by calculating the mean value of all informative STR markers. Again, the calculation can be done either manually or using a second Excel spread-
Figure 1A
Schematic representation of different donor recipient constellation after allogeneic transplantation. Details are given in section 4a-c.
sheet. The standard deviation from the mean should be calculated to control for strong variance which may be an indicator of methodological problems (see Troubleshooting section). The numbers indicate the ability to detect minor cell populations in samples displaying mixed chimerism. Levels of sensitivity higher than 5% are obtained particularly in the presence of homozygous alleles in the donor and/or the recipient.
III. Time requirement

V. Specificity/Informativeness
Due to the high resolution of the combination of nine STRs, recipient and donor can be identified unambiguously in the vast majority of cases: in a series of 390 recipient/donor constellations, only one pair could not be analyzed. This case, however, could be analyzed using the AmpFlSTR SGM plus kit which contains six additional STR markers not included in the Profiler assay.
Problems in specificity can arise from the so-called stutter peaks, ie n-1 alleles of the STR alleles present (Figure 2A) . Stutter peaks result from 'slippery' amplification of STR repeats during PCR where one 4 bp tandem repeat of the template is looped out during amplification. This results in the generation of products 4 bp shorter than the original STR repeat (for details see Walsh et al 3 ) . The stutter peaks are usually up to 5% of the size of the corresponding STR peak. In contrast to a recent publication, 2 we found stutter peaks particularly problematic if the recipient allele co-migrated with the stutter peak of a donor STR allele (illustrated in Figure 2A) . In rare cases, several of these constellations may be present and these STRs should not be used for quantitative analysis.
VI. Reproducibility/Accuracy
The variability of results observed in repeated quantitative analyses of individual STR-PCR specimens (ie PCR, electrophoresis and quantitative analysis of multiple aliquots derived from the same DNA) is in the range of 1-4% if performed in the same laboratory. It is possible therefore to determine changes in recipient chimerism if the difference between samples is greater than 5%.
VII. Costs of the assay
The overall costs per analysis are dependent on the total number of analyses performed. The numbers indicated are based on about 100 samples per week and parallel processing of 48 patient samples. • Amount of DNA too high or too low (see above)
• Allelic loss in one STR, especially frequent at Chr. 
